Video
Thank you for contacting us; we’ll be in touch shortly.
Phase 3 Planning: Serialization from the Sharp Packaging Perspective
If you're a Phase 3 pharma company, serialization will be part of your strategy. Watch Sharp SVPs discuss how they approach serialization.
China eCode or GS1 Encoding? Weighing the Benefits and Risks
China eCode or GS1 Encoding: Which one is right for you? Watch this short webinar excerpt to understand key considerations for your China product…
What's So Challenging about Continuous Compliance?
In the new regulatory landscape, maintaining compliance is a real challenge.
Inside Novant Health’s 5-Year Plan for DSCSA
Find out how how Novant Health plans to leverage DSCSA investments to create business value now and in the future.
Aurobindo Pharma, Serialization, and Best of Breed Expertise
Listen as Aurobindo Pharma's CIO explains the impact of serialization, and partnering with best in breed expertise.
CMO Line Upgrades: Who Will Pay?
Pharma companies and CMOs must work together closely to be ready for serialization, yet there is no established commercial model. Learn about the…
China Reporting and Compliance Systems: Key Considerations
What makes China compliance so challenging? Watch this brief overview of China’s 3-tier reporting system to help guide your China serialization…
Standardizing EPCIS for Pharma: The Sharp Packaging-TraceLink Partnership
Hear how CMO Sharp SVPs managed their RFP for an EPCIS solution, and why their need to standardize data formats led them to TraceLink.
Unlock Future Value with Serialized Receiving
DSCSA is driving supply chain digitalization across the pharmaceutical industry. Learn how TraceLink helps pharmacies achieve DSCSA compliance and…
Achieving Continuous Compliance with Automated Validation Manager
Learn how TraceLink's Automated Validation Manager (AVM) helps companies meet compliance requirements and stay focused on core business objectives.
What Role Does a 3PL Play in Global Markets?
3PLs provide an essential service for pharma brand owners, not just in the U.S. and EU, but in other markets such as Korea, China and Brazil. Find…
Will My Current China Reports Work with the New Traceability Systems?
Learn how China’s amended Drug Administration Law expands the scope of NMPA reporting requirements and impacts your company’s serialization strategy.